Essentially, this design emulated a randomised controlled trial, in which participants on a background therapy with one of the drug classes of interest (GLP-1 receptor agonists or SGLT-2 inhibitors) are randomised to either continue the background drug or add on the other drug of interest (SGLT-2 inhibitor or GLP-1 receptor agonist, respectively)
10.1038/ncomms7498 85
Since there are thousands of natural peptides and countless more synthetic ones, if you hear someone talk about a peptide, the first question should be Which one? What Is BPC-157 All About
As of June 2026, the official site describes GLPatch as containing a "GLP-1 Support Complex" - a proprietary blend of botanical extracts - without naming a single specific ingredient
Here, we found that exenatide (exendin-4) reduced adiposity by activating SIRT1 and consequently upregulating ATGL
Participants frequently report a reduction in blood sugar levels, leading to better glycemic control, which is especially significant for those managing diabetes